Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,616 | -38,759 | -32,396 | -24,686 | -8,288 |
| Depreciation Amortization | 291 | 1,140 | 840 | 557 | 306 |
| Accounts receivable | -222 | 126 | 84 | -14 | -1 |
| Accounts payable and accrued liabilities | 20 | -600 | -456 | -436 | -41 |
| Other Working Capital | -1,878 | 1,648 | 309 | 821 | 419 |
| Other Operating Activity | 3,377 | 101 | 818 | 160 | 854 |
| Operating Cash Flow | $-8,028 | $-36,344 | $-30,801 | $-23,598 | $-6,751 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,078 | -2,460 | 1,876 | -925 | -2,866 |
| PPE Investments | -84 | -252 | -253 | -168 | N/A |
| Investing Cash Flow | $4,994 | $-2,712 | $1,623 | $-1,093 | $-2,866 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 55 | 26,069 | 19,686 | 9,917 | N/A |
| Financing Cash Flow | $55 | $26,069 | $19,686 | $9,917 | $N/A |
| Beginning Cash Position | 9,279 | 22,266 | 22,266 | 22,266 | 22,266 |
| End Cash Position | 6,300 | 9,279 | 12,774 | 7,492 | 12,649 |
| Net Cash Flow | $-2,979 | $-12,987 | $-9,492 | $-14,774 | $-9,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,028 | -36,344 | -30,801 | -23,598 | -6,751 |
| Capital Expenditure | -84 | -252 | -253 | -168 | N/A |
| Free Cash Flow | -8,112 | -36,596 | -31,054 | -23,766 | -6,751 |